A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/1994
11/17/1994	EP0624371A1 Microcapsules for controlled release of acetylsalicylic acid
11/17/1994	EP0624366A1 Controlled release formulation containing tramadol
11/17/1994	EP0624195A1 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides
11/17/1994	EP0624099A1 Water soluble non-immunogenic polyamide cross-linking agents
11/17/1994	EP0624098A1 Process of conjugation of antiviral nucleosides with lactosaminated human albumin
11/17/1994	EP0624097A1 Targeting radioactive immunoreagents
11/17/1994	EP0605704A4 Starch-iodine-peroxide preservation of blood, tissues and biological fluids.
11/17/1994	EP0109441B1 Human-human hybridomas for neoplasms
11/16/1994	CN1094965A Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of b cell lymphoma
11/16/1994	CN1094950A Compositions of L-dopa esters
11/15/1994	US5364886 Stabilizers for fats
11/15/1994	US5364839 Osteoinductive pharmaceutical formulations
11/15/1994	US5364636 Inhibitor of absorption of digestion product of food and drink
11/15/1994	US5364633 Silicone vesicles and entrapment
11/15/1994	US5364629 Device and method for enhanced administration of physostigmine
11/15/1994	US5364622 Antisticking of organs
11/15/1994	US5364613 Polychelants containing macrocyclic chelant moieties
11/15/1994	US5364563 Powdered aqueous carotenoid dispersions
11/15/1994	US5363846 Method for the diagnosis and treatment of inflammation
11/15/1994	CA1333051C Method for the treatment of withdrawal symptoms associated with smoking cessation and preparations for use in said method
11/15/1994	CA1333048C Monoclonal antibodies against lens epithelial cells and methods for preventing proliferation of remnant lens epithelial cells after extracapsular extraction
11/11/1994	CA2123144A1 Stabilisation of pharmacologically active compounds in sustained release compositions
11/10/1994	WO1994025626A1 Dna profiles as an indicator of cellular redox potential and cancer risk
11/10/1994	WO1994025616A1 Cell-targeted lytic pore-forming agents
11/10/1994	WO1994025491A1 Fibrin-targeted inhibitors of thrombin
11/10/1994	WO1994025429A1 4-amino-fluorobenzamides and their use as cytotoxic prodrugs
11/10/1994	WO1994025075A1 Polymeric x-ray contrast compositions containing iodinated polymeric beads
11/10/1994	WO1994025072A1 Rapamycin conjugates and antibodies
11/10/1994	WO1994025071A1 Polyoxime compounds and their preparation
11/10/1994	WO1994025070A1 Veterinary composition containing a proton pump inhibitor
11/10/1994	WO1994025069A1 Transdermal active-substance preparation
11/10/1994	WO1994025068A1 Improved pharmaceutical acceptable compositions containing an alcohol and a hydrophobic drug
11/10/1994	WO1994025066A1 COMBINED TREATMENT OF IRON DEPLETION AND IgG ANTIBODY
11/10/1994	WO1994025062A1 Oral pharmaceutical compositions containing renin inhibitors
11/10/1994	WO1994025053A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
11/10/1994	WO1994025039A1 Composition containing cholestyramine and method of producing the same
11/10/1994	WO1994025032A1 Stabilized injection and method of stabilizing injection
11/10/1994	WO1994025025A2 Systems for controlled release of pilocarpine
11/10/1994	WO1994025022A1 Rapamycin conjugates and antibodies
11/10/1994	WO1994025010A1 Solid form of administration of isosorbide 5-mononitrate
11/10/1994	WO1994025009A1 Coated pharmaceutical compositions
11/10/1994	WO1994025008A1 Pharmaceutical compositions containing polyvinylpyrrolidone and a tri-ester and process of manufacture thereof
11/10/1994	WO1994025007A1 Stable, ingestable and absorbable nadh and nadph therapeutic compositions
11/10/1994	WO1994025004A1 Synthetic viscoelastic material for ophthalmic applications
11/10/1994	WO1994024990A1 Intraoral composition
11/10/1994	WO1994024984A2 Anti-inflammatory compositions containing eicosapentaenoic acid bearing monogalactosyldiacylglycerol and methods relating thereto
11/10/1994	WO1994024983A2 Ocular delivery of nucleic acid
11/10/1994	WO1994024959A1 Method of detecting compounds utilizing chemically modified lambdoid bacteriophage
11/10/1994	WO1994024863A1 Aqueous compositions comprising an organic peroxiacid
11/10/1994	WO1994021656A3 Novel phospholipid-saccharide conjugates
11/10/1994	DE4414544A1 Depot tablet
11/10/1994	CA2162157A1 Polyoxime compounds and their preparation
11/10/1994	CA2161785A1 Injectable polysaccharide-cell compositions
11/10/1994	CA2161772A1 Fibrin-targeted inhibitors of thrombin
11/10/1994	CA2161656A1 Combined treatment of iron depletion and igg antibody
11/10/1994	CA2161531A1 Dna profiles as an indicator of cellular redox potential and cancer risk
11/10/1994	CA2161520A1 Systems for controlled release of pilocarpine
11/10/1994	CA2161438A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
11/10/1994	CA2161434A1 Polymeric x-ray contrast compositions containing iodinated polymeric beads
11/10/1994	CA2161217A1 Coated pharmaceutical compositions
11/10/1994	CA2161101A1 Rapamycin conjugates and antibodies
11/10/1994	CA2160909A1 Cell-targeted lytic pore-forming agents
11/10/1994	CA2160880A1 Improved pharmaceutical acceptable compositions containing an alcohol and a hydrophobic drug
11/10/1994	CA2160704A1 Ocular delivery of nucleic acid
11/10/1994	CA2160247A1 Composition containing cholestyramine and method of producing the same
11/10/1994	CA2159716A1 Method of detecting compounds utilizing chemically modified lambdoid bacteriophage
11/10/1994	CA2139569A1 Aqueous compositions comprizing and organic peroxyacid
11/09/1994	EP0652754A4 Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application.
11/09/1994	EP0623675A1 Altered affinity polypeptides of metal chelate binding antibodies
11/09/1994	EP0623352A2 Bifunctional glycoproteins having a modified carbohydrate complement, and their use in tumorselective therapy
11/09/1994	EP0623349A1 Solvent for a sparingly soluble gentamicin salt
11/09/1994	EP0623026A1 Detoxified lps-cholera toxin conjugate vaccine for prevention of cholera
11/09/1994	EP0623025A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
11/09/1994	EP0616493A4 Methods and compositions for reducing multi-drug resistance.
11/09/1994	EP0576612A4 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity.
11/09/1994	EP0436664B1 Cleavable linkers for the reduction of non-target organ retention of immunoconjugates
11/09/1994	CN1094752A Prescription for stabilizator of rheumatism-traumatic medicinal liquor
11/09/1994	CN1094643A Plasticized bioerodible controlled delivery system
11/09/1994	CN1094621A Plaster for preventing and treating infant's diarrhoea and anorexia and preparing process thereof
11/09/1994	CN1094614A Antiallergic composition for ophthalmic or nasal use
11/09/1994	CN1094611A Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
11/09/1994	CN1094610A Bioerodible controlled delivery system
11/09/1994	CN1026463C Chewable capsules
11/08/1994	US5362860 Neutral stabilization complex for CI-979 HCl, a cognition activator
11/08/1994	US5362858 Polyethylene glycol-hirudin conjugates, process for preparing them and their use for the treatment of thromboses
11/08/1994	US5362852 Modified peptide derivatives conjugated at 2-hydroxyethylamine moieties
11/08/1994	US5362831 Polymer-bound paclitaxel derivatives
11/08/1994	US5362643 Immunoglobulin chains with bound antibodies for immunology
11/08/1994	US5362565 Production method of microcapsules
11/08/1994	US5362498 Process for preparing a bioadhesive pharmaceutical dosage form and pharmaceutical dosage form thus prepared
11/08/1994	US5362497 Transdermal therapeutic composition
11/08/1994	US5362494 Cosmetic, dermo-pharmaceutical or vesicle-containing composition including clycerol-derived compounds
11/08/1994	US5362478 Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
11/08/1994	US5362474 Method for detecting and locating inflammatory or tumor foci in a patient and diagnostic kit therefor
11/08/1994	US5362424 Microencapsulation for controlled oral drug delivery system
11/08/1994	US5362420 Low impedance pressure sensitive adhesive composition and biomedical electrodes using same
11/08/1994	CA1332941C N-alkylated quaternary nitrogen containing heterocycles
11/08/1994	CA1332940C N-alkylated quaternary nitrogen-containing heterocycles
11/08/1994	CA1332939C 2,5,6-substituted-n -alkylpyrimidines
11/08/1994	CA1332938C N-alkylated quaternary nitrogen-containing heterocycles

1 ... 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 ... 1712